Company

SL VaxiGen Inc.

SL VaxiGen develops DNA-based vaccines and other vaccine therapies for infectious diseases and cancer.

About

Founded in 2017 and based in Seongnam, South Korea, SL VaxiGen develops vaccines using DNA vaccine and B.S.A platform technologies. Its pipeline includes SL-V10, SL-V20, and SL-V30 for infectious diseases and SL-V60 for cancer.

3Funding rounds

8Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in